Association of VEGF gene polymorphisms with the development of heart failure in patients after myocardial infarction

Cardiology

Volumn 114, Issue 1, 2009, Pages 11-18

  Douvaras, Panagiotis ^a,c   Antonatos, Dionisios G ^b   Kekou, Kiriaki ^a   Patsilinakos, Sotirios ^b   Chouliaras, George ^a   Christou, Apostolos ^b   Andrikou, Anastasios ^b   Kanavakis, Emmanuel ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

^c NONE   (United Kingdom)

Author keywords

Acute myocardial infarction; Restriction fragment length polymorphism; Single nucleotide polymorphism; Vascular endothelia growth factor

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HEART FAILURE; HEART INFARCTION; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; GENETIC MARKERS; GENOTYPE; GREECE; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 63049129707     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210189     Document Type: Article

References (47)

1. Lip GY, Chung I: Vascular endothelial growth factor and angiogenesis in heart failure. J Card Fail 2005;11:285-287.
2. Schaper W, Buschmann I: Arteriogenesis, the good and bad of it. Cardiovasc Res 1999;43:835-837.
3. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W: Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 1998;101:40-50.
4. Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, Doi K, Ogawa Y, Tamura N, Takaya K, Igaki T, Yamashita J, Chun TH, Masatsugu K, Becker AE, Nakao K: Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998;98:2108-2116.
5. Chen YX, Nakashima Y, Tanaka K, Shiraishi S, Nakagawa K, Sueishi K: Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries. Arterioscler Thromb Vasc Biol 1999;19:131-139.
6. Leung DW, Cachianes G, Kuang WJ, Goed-del DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-1309.
7. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983-985.
8. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D: Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990;172:1535-1545.
9. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
10. Claffey KP, Brown LF, del Aguila LF, Tognazzi K, Yeo KT, Manseau EJ, Dvorak HF: Expression of vascular permeability factor/ vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res 1996;56:172-181.
11. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, Ferrara N: Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid ar thritis. J Immunol 1994;152: 4149-4156.
12. Miller JW, Adamis AP, Shima DT, D'Amore PA, Moulton RS, O'Reilly MS, Folkman J, Dvorak HF, Brown LF, Berse B, et al: Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994;145:574-584.
13. Kim SH, Choi YM, Choung SH, Jun JK, Kim JG, Moon SY: Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis. Hum Reprod 2005;20: 2904-2908.
14. Hojo Y, Ikeda U, Zhu Y, Okada M, Ueno S, Arakawa H, Fujikawa H, Katsuki T, Shimada K: Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J Am Coll Cardiol 2000;35:968-973.
15. Kawamoto A, Kawata H, Akai Y, Katsuyama Y, Takase E, Sasaki Y, Tsujimura S, Sakaguchi Y, Iwano M, Fujimoto S, Hashimoto T, Dohi K: Serum levels of VEGF and basic FGF in the subacute phase of myocardial infarction. Int J Cardiol 1998;67:47-54.
16. Lee KW, Lip GY, Blann AD: Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation 2004;110:2355-2360.
17. Chin BS, Chung NA, Gibbs CR, Blann AD, Lip GY: Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure. Am J Cardiol 2002;90: 1258-1260.
18. Van der Meer P, De Boer RA, White HL, van der Steege G, Hall AS, Voors AA, van Veldhuisen DJ: The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy. J Card Fail 2005;11:279-284.
19. Petrovic D, Verhovec R, Globocnik Petrovic M, Osredkar J, Peterlin B: Association of vascular endothelial growth factor gene polymorphism with myocardial infarction in patients with type 2 diabetes. Cardiology 2007;10 7: 291-295.
20. Renner W, Kotschan S, Hoffmann C, Ober-mayer-Pietsch B, Pilger E: A common 936 C/ T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000;37:443-448.
21. Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, Hutchinson IV: Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 1999;60:1245-1249.
22. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE: Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000;12:1232-1235.
23. Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, Inoue I, Katayama S: A common polymorphism in the 5′-untrans-lated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002;51:1635-1639.
24. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991;266:11947-11954.
25. Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW: Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 2003;63: 812-816.
26. Hansen JF: Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion. Am Heart J 1989;117:290-295.
27. Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, Terrin ML, Bolli R: Influence of coronary collateral vessels on myocardial infarct size in humans: results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation 1991;83:739-746.
28. Ogawa H, Suefuji H, Soejima H, Nishiyama K, Misumi K, Takazoe K, Miyamoto S, Kajiwara I, Sumida H, Sakamoto T, Yoshimura M, Kugiyama K, Yasue H, Matsuo K: Increased blood vascular endothelial growth factor levels in patients with acute myocardial infarction. Cardiology 2000;93:93-99.
29. Schultz A, Lavie L, Hochberg I, Beyar R, Stone T, Skorecki K, Lavie P, Roguin A, Levy AP: Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 1999;100: 547-552.
30. Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, AlChalabi A, Bornes S, Musson R, Hansen V, Beckman L, Adolfsson R, Pall HS, Prats H, Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison KE, Robberecht W, Van Broeckhoven C, Collen D, Andersen PM, Carmeliet P: VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneu-rons against ischemic death. Nat Genet 2003;34:383-394.
31. Heeschen C, Dimmeler S, Hamm CW, Boersma E, Zeiher AM, Simoons ML;Capture (c7E3 Anti-Platelet Therapy in Unstable Refractory Angina) Investigators: Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes. Circulation 2003;107:524-530.
32. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF: Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994;89:2183-2189.
33. Losordo DW, Vale PR, Symes JF, Dunning-ton CH, Esakof DD, Maysky M, Ashare AB, Lathi K, Isner JM: Gene therapy for myocar-dial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 a s s oet herapy for myoc a rd i a l i schemia . Ci r-culation 1998;98:2800-2804.
34. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6: 389- 395.
35. Moulton KS, Vakili K, Zurakowski D, Soli-man M, Butterfield C, Sylvin E, Lo KM, Gillies S, Java her ia n K, Fol kman J: Inh ibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 2003;10 0 : 4736-4741.
36. Howell WM, Ali S, Rose-Zerilli MJ, Ye S: VEGF polymorphisms and severity of atherosclerosis. J Med Genet 2005;42:485-490.
37. Comings DE, MacMurray JP: Molecular het-erosis: a review. Mol Genet Metab 2000;71: 19 -31.
38. Salvarani C, Boiardi L, Casali B, Olivieri I, Cantini F, Salvi F, Malatesta R, La Corte R, Tr iolo G, Fer ra nte A, Fi lippi ni D, Paola zzi G, S a r z i-P ut t i n i P, Nic ol i D, Fa r net t i E , Che n Q, Pulsatelli L: Vascular endothelial growth factor gene polymorphisms in Behcet's disease. J Rheumatol 200431:1785-1789.
39. Boiardi L, Casali B, Nicoli D, Farnetti E, Chen Q, M acchioni P, Catanoso MG, Pul-satelli L, Meliconi R, Salvarani C: Vascular endothelial growth factor gene polymorphisms in giant cell arteritis. J Rheumatol 2003;30:2160-2164.
40. Young HS, Summers AM, Bhushan M, Brenchley PE, Griffiths CE: Single-nucleo-tide polymorphisms of vascular endothelial growth factor in psoriasis of early onset. J Invest Dermatol 2004;122:209-215.
41. Yang B, Cross DF, Ollerenshaw M, Millward BA, Demaine AG: Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mel-litus. J Diabetes Complications 2003;17:1-6.
42. Del Bo R , Scarlato M, Ghezzi S , Maestroni A , Sjolind L, Forsblom C, Wessman M, Groop PH, Comi GP, Bresolin N, Luzi L, Zerbini G: VEGF gene variability and type 1 diabetes: evidence for a protective role. Immunogenetics 2006;58:107-112.
43. Suganthalakshmi B, Anand R, Kim R, Mahalakshmi R, Karthikprakash S, Namperumalsamy P, Sundaresan P: Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol Vis 2006;12: 336-341.
44. Papazoglou D, Galazios G, Koukourakis MI, Kontomanolis EN, Maltezos E: Association of -634G/C and 936C/T polymorphisms of the vascular endothelial growth factor with spontaneous preterm delivery. Acta Obstet Gynecol Scand 2004;83:461-465.
45. Papazoglou D, Galazios G, Koukourakis MI, Panagopoulos I, Kontomanolis EN, Papatheodorou K, Maltezos E: Vascular endothelial growth factor gene polymorphisms and pre-eclampsia. Mol Hum Reprod 2004;10:321-324.
46. Papazoglou D, Galazios G, Papatheodorou K, Liberis V, Papanas N, Maltezos E, Maroulis GB: Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnanc y loss. Fertil Steril 2005;83: 959-963.
47. Tzanakis N, Gazouli M, Rallis G, Giannopoulos G, Papaconstantinou I, Theodoropoulos G, Pikoulis E, Tsigris C, Karakitsos P, Peros G, Nikiteas N: Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol 2006;94:624-630.